Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MME | P08473 | 2/20 | 0.44 |
| ▸ | LTA4H | P09960 | 1/20 | 0.44 |
| ▸ | LAP3 | P28838 | 3/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29531330 | 1.00 | MME (0.44) | MMELTA4HLAP3 | |
| SCHEMBL1666827 | 1.00 | MME (0.44) | MMELTA4HLAP3 | |
| Water SCHEMBL29559377 | 0.99 | MME (0.44) | MMELTA4HLAP3 | |
| SCHEMBL30728878 | 0.98 | MME (0.43) | MMELTA4HLAP3 | |
| SCHEMBL34470345 | 0.96 | MME (0.42) | MMELTA4HLAP3 | |
| SCHEMBL30973978 | 0.95 | OPRM1 (0.42) | MMELTA4HLAP3 | |
| SCHEMBL29442611 | 0.95 | MME (0.41) | MMELTA4HLAP3 | |
| SCHEMBL29531532 | 0.94 | MME (0.41) | MMELTA4HLAP3 | |
| SCHEMBL30495730 | 0.92 | BACE1 (0.41) | MMELTA4H | |
| SCHEMBL29757021 | 0.92 | MME (0.42) | MMELTA4HLAP3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 485 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250295762-A1 | COMPOSITE BIOACTIVE COMPOSITIONS AND APPLICATIONS THEREOF | THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL | 2025-09-25 | — | — | US | claimed |
| CN-114507696-B | Preparation method of sorghum extract | 浙江工业大学 | 2024-03-15 | — | — | CN | claimed |
| CN-117230048-A | Threonine aldolase mutant with improved stereoselectivity and application thereof | 浙江工业大学 | 2023-12-15 | — | — | CN | claimed |
| CN-115047120-A | Dansyl chloride derivatization method for analyzing and detecting dipeptide substances in white spirit Daqu | 贵州茅台酒股份有限公司 | 2022-09-13 | — | — | CN | claimed |
| CN-114958362-A | Preparation method of BL-CQDs fluorescent probe and application of BL-CQDs fluorescent probe in ACE activity detection and ACEI screening | 岭南师范学院 | 2022-08-30 | — | — | CN | claimed |
| CN-114507696-A | Preparation method of kaoliang essence | 浙江工业大学 | 2022-05-17 | — | — | CN | claimed |
| EP-2124880-B1 | FLUORESCENT NANOPARTICLES | EXCHANGE IMAGING TECH GMBH (DE) | 2018-03-21 | — | — | EP | claimed |
| EP-1787659-B1 | Fluorescent nanoparticles | EXCHANGE IMAGING TECH GMBH (DE) | 2017-03-22 | — | — | EP | claimed |
| US-8974767-B2 | Fluorescent nanoparticles | SIGNALOMICS GMBH (AT) | 2015-03-10 | — | — | US | claimed |
| CN-101360515-B | Fluorescent nanoparticles | SIGNALOMICS GMBH | 2014-03-19 | — | — | CN | claimed |
| WO-2007057182-A2 | FLUORESCENT NANOPARTICLES | SIGNALOMICS GMBH (AT) | 2007-05-24 | — | — | WO | claimed |
| EP-1787659-A1 | Fluorescent nanoparticles | Signalomics GmbH (DE) | 2007-05-23 | — | — | EP | claimed |
| WO-2007001438-A2 | FUNCTIONALIZED FLUORESCENT NANOCRYSTALS, AND METHODS FOR THEIR PREPARATION AND USE | MOLECULAR PROBES, INC. (US) | 2007-01-04 | — | — | WO | claimed |
| US-20060216759-A1 | Functionalized fluorescent nanocrystals, and methods for their preparation and use | Life Technologies Corporation | 2006-09-28 | — | — | US | claimed |
| EP-0226304-B1 | COMPOSITION CONTAINING A PENEM OR CARBAPENEM ANTIBIOTIC | SANKYO COMPANY LIMITED (JP) | 1991-08-28 | — | — | EP | claimed |
| US-4757066-A | Reduces renal toxicity | SANKYO COMPANY LIMITED (JP) | 1988-07-12 | — | — | US | claimed |
| EP-0148193-B1 | METHOD AND REAGENT FOR THE DETERMINATION OF ANGIOTENSIN CONVERTING ENZYME | Roche Diagnostics GmbH (DE) | 1987-08-12 | — | — | EP | claimed |
| EP-0226304-A1 | Composition containing a penem or carbapenem antibiotic | SANKYO COMPANY LIMITED (JP) | 1987-06-24 | — | — | EP | claimed |
| CN-86107574-A | Compositions containing penem or carbapenem antibiotics and their use | — | 1987-05-20 | — | — | CN | claimed |
| US-4108726-A | Sarcoidosis test | RESEARCH CORPORATION (US) | 1978-08-22 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250295762-A1 | COMPOSITE BIOACTIVE COMPOSITIONS AND APPLICATIONS THEREOF | BMP2, BMP1, MATR3 | MME 3208/4885LTA4H 1858/4885LAP3 3278/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.